aspirin and terbogrel

aspirin has been researched along with terbogrel in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gams, E; Hohlfeld, T; Kienzle, P; Kim, U; Schrör, K; Weber, AA; Wenk, A; Zimmermann, N	1
Guth, BD; Narjes, H; Nehmiz, G; Riedel, A; Schubert, HD; Tanswell, P	1
Giannitsis, E; Hohlfeld, T; Ivandic, BT; Katus, HA; Schlick, P; Staritz, P	1

Trials

2 trial(s) available for aspirin and terbogrel

Article	Year
Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery. Circulation, 2003, Aug-05, Volume: 108, Issue:5 Topics: Arachidonic Acid; Aspirin; Blood Platelets; Collagen; Coronary Artery Bypass; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Resistance; Enzyme Activation; Humans; Indomethacin; Isoenzymes; Membrane Proteins; P-Selectin; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Pyridines; Thromboxane-A Synthase; Thromboxanes; Time Factors	2003
Pharmacokinetics and pharmacodynamics of terbogrel, a combined thromboxane A2 receptor and synthase inhibitor, in healthy subjects. British journal of clinical pharmacology, 2004, Volume: 58, Issue:1 Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Bleeding Time; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Male; Platelet Aggregation; Pyridines; Thromboxane A2; Thromboxane-A Synthase	2004

Article

Year

Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.

Circulation, 2003, Aug-05, Volume: 108, Issue:5

Topics: Arachidonic Acid; Aspirin; Blood Platelets; Collagen; Coronary Artery Bypass; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Resistance; Enzyme Activation; Humans; Indomethacin; Isoenzymes; Membrane Proteins; P-Selectin; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Pyridines; Thromboxane-A Synthase; Thromboxanes; Time Factors

2003

Pharmacokinetics and pharmacodynamics of terbogrel, a combined thromboxane A2 receptor and synthase inhibitor, in healthy subjects.

British journal of clinical pharmacology, 2004, Volume: 58, Issue:1

Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Bleeding Time; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Male; Platelet Aggregation; Pyridines; Thromboxane A2; Thromboxane-A Synthase

2004

Other Studies

1 other study(ies) available for aspirin and terbogrel

Article	Year
Determination of aspirin responsiveness by use of whole blood platelet aggregometry. Clinical chemistry, 2007, Volume: 53, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Blood Donors; Clopidogrel; Collagen; Coronary Artery Disease; Drug Resistance; Electric Impedance; Female; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridines; Reference Values; Sex Factors; Thromboxane B2; Ticlopidine	2007

Article

Year

Determination of aspirin responsiveness by use of whole blood platelet aggregometry.

Clinical chemistry, 2007, Volume: 53, Issue:4

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Blood Donors; Clopidogrel; Collagen; Coronary Artery Disease; Drug Resistance; Electric Impedance; Female; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridines; Reference Values; Sex Factors; Thromboxane B2; Ticlopidine

2007